International Health-Tech R&D and Pilot Programs

תאריך אחרון להגשה 

21/06/2023

חטיבות

Growth, International Collabration

תיאור הקול הקורא

Summary

The Israel Innovation Authority and selected international health centers jointly open the International Health-Tech Partnership Program.

This Call for proposals is open exclusively for Israeli companies that were approved during the perliminary phase of the program by the partnering entities.

Approved Israeli companies are invited to submit applications to co-develop, pilot, test, adapt and optimize impactful healthcare-related technologies, services, and devices in a clinical environment at leading global hospitals (listed in alphabetic order):

Participating Agencies

Charité – Universitätsmedizin Berlin (Charité)
Hartford HealthCare
Mayo Clinic
Northern Health Science Alliance (NHSA) – UK
Thomas Jefferson University Hospitals – USA

Relevant Technologies

Healthcare-related technologies, services, and devices. Each hospital has unique interest areas, listed in the program guidelines.

RFP Description

The goals of the collaboration are to stimulate transnational partnerships, accelerate the availability of medical innovations to the public, introduce Israeli healthcare technology to global markets, and advance the development of discoveries for the benefit of patients all over the world.

The programs are operating under the Israel Innovation Authority’s International Rules & Regulations and the R&D Fund Incentive Program: https://innovationisrael.org.il/en/program/bilateral-programs-parallel-support

Criteria

  • This Call for proposals is open exclusively for Israeli companies that were approved during the perliminary phase of the program by the partnering entities.
  • Applicants must be registered and operating companies in Israel.
  • The proposed project will be examined based on its innovation and excellence level, impact, the synergy between the partners, the capacity to execute, and the challenge it is trying to solve.
  • The criteria for evaluation and preconditions are detailed in the Israel Innovation Authority’s Internatioanl Rules & Regulations per this link

Funding

Successful applicant companies will receive from the Israel Innovation Authority funding of 20%-50% of the approved R&D budget, in addition to support from the partnering hospital.

Please see the full details in the following Program Guidelines (listed in alphabetic order):  

Application Process

Israeli Companies should submit joint applications for R&D and/or Pilot projects no later than June 21, 2023, at 12:00 (IST).

Applicants are required to follow the local requirements and use the provided application format and instructions. Applications that are not in the approved format will not be accepted.
Results will be sent after the committees on both sides make their decisions.